StonvexLoading…
StonvexStonvexStonvexCore line items from CGNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q2 2026 2026-04-05 | Annual 2025 2025-12-31 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|---|
Revenue | $291.55M | $268.44M | $994.36M | $742.02M | $465.13M |
Operating Income | Not available | $59.87M | $162.57M | $127.29M | $69.53M |
Net Income | Not available | $51.70M | $114.44M | $81.78M | $64.11M |
EPS (Diluted) | $0.41 | $0.31 | $0.68 | $0.48 | $0.38 |
Total Assets | Not available | $2.01B | $2.02B | $2.00B | $2.00B |
Total Liabilities | Not available | $526.65M | $524.65M | $513.11M | $497.48M |
Cash & Equivalents | Not available | $237.34M | $262.93M | $245.90M | $179.31M |
Free Cash Flow OCF − CapEx | Not available | $42.34M | $236.77M | $164.47M | $78.43M |
Shares Outstanding | Not available | 166.53M | 167.00M | 167.55M | 167.90M |